Overview

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

Status:
Completed

Trial end date:
2003-10-01

Target enrollment:

Participant gender:

Summary

Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the treatment of these gastric ulcers with one of the three following treatment groups: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; or ranitidine 150 mg twice daily.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Anti-Inflammatory Agents, Non-Steroidal
Esomeprazole
Ranitidine
Ranitidine bismuth citrate